Recommended
The Science of Cancer
- The past few years have seen tremendous strides in our understanding of cancer, including new hypotheses about its genetic origins and new treatment alternatives using the body’s own immune response.
- $6.99
Stories by Rob High and Jho Low
Rob High is the Chief Technology Officer of IBM Watson, where he leads the technical strategy and thought leadership of IBM Watson. Follow IBM Watson on Twitter@IBMWatson
Jho Low is the Chief Executive Officer of Jynwel Capital Limited and Director of Jynwel Charitable Foundation Limited, which looks to fund breakthrough programs that help scale and accelerate advancements in health. Follow on Twitter @jho_low Follow Rob High and Jho Low on Twitter @IBMWatson, @jho_low
Mind & Brain
Expert Cancer Care May Soon Be Everywhere, Thanks to Watson
This blog is the first in a series of guest posts on technology and the brain to celebrate Scientific American Mind’s 10-year anniversary.
